REGENXBIO Inc. (NASDAQ:RGNX) Q2 2024 Earnings Call Transcript August 1, 2024
REGENXBIO Inc. beats earnings expectations. Reported EPS is $-1.05, expectations were $-1.29.
Operator: Welcome everyone to the Q2 2024 REGENXBIO’s Earnings Conference Call. All lines have been placed on mute to prevent background noise. After the speakers’ remarks, there will be a question-and-answer session. [Operator Instructions] At this time, I’d like to turn the conference over to Patrick Christmas, Chief...
